All News

Globus Medical Appoints David M. Demski as CEO

AUDUBON, Penn., Aug. 29, 2017 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that, the Board of Directors has named David M. Demski as the Company’s Chief Executive Officer, effective immediately.  Mr. Demski will report to David C. Paul, the Company’s founder, Chairman of […]

OrthoPediatrics and Mighty Oak Medical Team Up to Bring Pediatric-Friendly Spinal Navigation to Children’s Hospitals

WARSAW, Ind., Aug. 28, 2017 (GLOBE NEWSWIRE) — OrthoPediatrics and Mighty Oak Medical are pleased to announce a navigation partnership that can provide unsurpassed screw placement accuracy in the pediatric population.  Mighty Oak Medical is the manufacturer of FIREFLY® Pedicle Screw Navigation Guides, which are 3D printed and patient-specific at each planned […]

NuVasive Announces World-Class Innovation Center At San Diego Headquarters

SAN DIEGO, Aug. 29, 2017 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the expansion of its San Diego global headquarters, including the creation of an innovation center of excellence where surgeons from around the world will be educated […]

Anika Announces Appointment of Steven Chartier as Vice President of Regulatory and Clinical Affairs

August 28, 2017 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today announced the appointment of Steven Chartier as Vice President of Regulatory and Clinical Affairs. Mr. Chartier brings more than 25 years of operational expertise […]

MicroPort Orthopedics Announces Launch of its Procotyl® Prime Acetabular Cup System for Total Hip Replacement Surgery

August 29, 2017 ARLINGTON, Tenn.–(BUSINESS WIRE)–MicroPort Orthopedics, a medical device company that develops and manufactures cutting-edge joint replacement implants and approaches, today announced the launch of its Procotyl® Prime Acetabular Cup System. “At MicroPort Orthopedics, we embrace the constant advance in orthopedic medicine, and have a deep commitment to creating […]

Allegra Orthopaedics making progress on bone substitute technology

28 Aug 2017 Allegra Orthopaedics Ltd (ASX:AMT) is continuing to make significant progress with its unique bone substitute technology “Sr-HT-Gahnite” and is aiming to progress into the production phase. The company is an orthopaedic manufacturer and has obtained the global license to the composite biocompatible ceramic material known as Sr-HT- Gahnite […]

FDA Commissioner Scott Gottlieb, M.D. on FDA’s new policy steps and enforcement efforts of stem cell therapies and regenerative medicine

SILVER SPRING, Md., Aug. 28, 2017 /PRNewswire-USNewswire/ — One of the most promising new fields of science and medicine is the area of cell therapies and their use in regenerative medicine. These new technologies, most of which are in early stages of development, hold significant promise for transformative and potentially curative treatments […]

Regentis Biomaterials Receives European CE Mark Approval for GelrinC

OR AKIVA, Israel and PRINCETON, New Jersey, August 28, 2017 /PRNewswire/ — Regentis Biomaterials Ltd., a privately held company developing proprietary hydrogels for tissue regeneration, announced today it has received European CE mark approval for its GelrinC® biodegradable implant. The approval covers GelrinC manufactured using denatured human fibrinogen and expands upon the existing CE mark […]

Kuros receives clearance for MagnetOs Putty for commercialization in the United States and files the product for CE marking in Europe

Schlieren (Zurich), Switzerland, August 28, 2017 – Kuros Biosciences announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for MagnetOs Putty indicated for use as an autograft extender in posterolateral spine. This market clearance allows commercialization of MagnetOs Putty in the United States […]

Mainstay Medical to seek further funding as full-year losses mount

Aug 24, 2017 – Charlie Taylor Dublin-listed Mainstay Medical, a company that is targeting chronic back pain with an implantable device, is expecting to seek further funding in the near future as it ramps up its commercialisation plans. The medical devices firm, which recently announced it had passed the mid-point in clinical […]

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.4